<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33399966</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>268</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Cortical progression patterns in individual ALS patients across multiple timepoints: a mosaic-based approach for clinical use.</ArticleTitle><Pagination><StartPage>1913</StartPage><EndPage>1926</EndPage><MedlinePgn>1913-1926</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-020-10368-7</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The majority of imaging studies in ALS infer group-level imaging signatures from group comparisons, as opposed to estimating disease burden in individual patients. In a condition with considerable clinical heterogeneity, the characterisation of individual patterns of pathology is hugely relevant. In this study, we evaluate a strategy to track progressive cortical involvement in single patients by using subject-specific reference cohorts.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We have interrogated a multi-timepoint longitudinal dataset of 61 ALS patients to demonstrate the utility of estimating cortical disease burden and the expansion of cerebral atrophy over time. We contrast our strategy to the gold-standard approach to gauge the advantages and drawbacks of our method. We modelled the evolution of cortical integrity in a conditional growth model, in which we accounted for age, gender, disability, symptom duration, education and handedness. We hypothesised that the variance associated with demographic variables will be successfully eliminated in our approach.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In our model, the only covariate which modulated the expansion of atrophy was motor disability as measured by the ALSFRS-r (t(153)&#x2009;=&#x2009;-&#xa0;2.533, p&#x2009;=&#x2009;0.0123). Using the standard approach, age also significantly influenced progression of CT change (t(153)&#x2009;=&#x2009;-&#xa0;2.151, p&#x2009;=&#x2009;0.033) demonstrating the validity and potential clinical utility of our approach.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our&#xa0;strategy of estimating the extent of cortical atrophy in individual patients with ALS successfully corrects for demographic factors and captures relevant cortical changes associated with clinical disability. Our approach provides a framework to interpret single T1-weighted images in ALS and offers an opportunity to track cortical propagation patterns both at individual subject level and at cohort level.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tahedl</LastName><ForeName>Marlene</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Computational Neuroimaging Group, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse Street, Dublin 2, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, University of Regensburg, 93053, Regensburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Psychology, University of Regensburg, 93053, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chipika</LastName><ForeName>Rangariroyashe H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Computational Neuroimaging Group, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse Street, Dublin 2, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lope</LastName><ForeName>Jasmin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Computational Neuroimaging Group, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse Street, Dublin 2, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li Hi Shing</LastName><ForeName>Stacey</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Computational Neuroimaging Group, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse Street, Dublin 2, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardiman</LastName><ForeName>Orla</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Computational Neuroimaging Group, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse Street, Dublin 2, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bede</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0492-4772</Identifier><AffiliationInfo><Affiliation>Computational Neuroimaging Group, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse Street, Dublin 2, Ireland. bedep@tcd.ie.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HRB EIA-2017-019</GrantID><Agency>Health Research Board (HRB)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C565957">Amyotrophic Lateral Sclerosis 2, Juvenile</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Neurol Neurosurg Psychiatry. 2022 Jan;93(1):3</RefSource><PMID Version="1">34663624</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006233" MajorTopicYN="Y">Disabled Persons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068079" MajorTopicYN="Y">Motor Disorders</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Cortical thickness</Keyword><Keyword MajorTopicYN="N">Longitudinal study</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">Neuroimaging</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>5</Day><Hour>12</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33399966</ArticleId><ArticleId IdType="doi">10.1007/s00415-020-10368-7</ArticleId><ArticleId IdType="pii">10.1007/s00415-020-10368-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eisen, A., et al., Amyotrophic lateral sclerosis: a long preclinical period? J Neurol Neurosurg Psychiatry, 2014.</Citation></Reference><Reference><Citation>Querin G et al (2019) Presymptomatic spinal cord pathology in c9orf72 mutation carriers: A longitudinal neuroimaging study. Ann Neurol 86(2):158&#x2013;167</Citation><ArticleIdList><ArticleId IdType="pubmed">31177556</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9;, D.E., et al., Deficits in verbal fluency in presymptomatic C9orf72 mutation gene carriers-a developmental disorder. J Neurol Neurosurg Psychiatry, 2020.</Citation></Reference><Reference><Citation>Miller T et al (2020) Phase 1&#x2013;2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. N Engl J Med 383(2):109&#x2013;119</Citation><ArticleIdList><ArticleId IdType="pubmed">32640130</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H, Brooks BR, Silani V (2014) Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved? Lancet Neurol 13(11):1127&#x2013;1138</Citation><ArticleIdList><ArticleId IdType="pubmed">25316019</ArticleId></ArticleIdList></Reference><Reference><Citation>Chipika RH et al (2019) Tracking a Fast-Moving Disease: Longitudinal Markers, Monitoring, and Clinical Trial Endpoints in ALS. Front Neurol 10:229</Citation><ArticleIdList><ArticleId IdType="pubmed">30941088</ArticleId><ArticleId IdType="pmc">6433752</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C et al (2015) Presymptomatic and longitudinal neuroimaging in neurodegeneration&#x2013;from snapshots to motion picture: a systematic review. J Neurol Neurosurg Psychiatry 86(10):1089&#x2013;1096</Citation><ArticleIdList><ArticleId IdType="pubmed">25632156</ArticleId></ArticleIdList></Reference><Reference><Citation>Proudfoot M, Bede P, Turner MR (2018) Imaging Cerebral Activity in Amyotrophic Lateral Sclerosis. Front Neurol 9:1148</Citation><ArticleIdList><ArticleId IdType="pubmed">30671016</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C, Hardiman O, Bede P (2016) Development of an Automated MRI-Based Diagnostic Protocol for Amyotrophic Lateral Sclerosis Using Disease-Specific Pathognomonic Features: A Quantitative Disease-State Classification Study. PLoS ONE 11(12):e0167331</Citation><ArticleIdList><ArticleId IdType="pubmed">27907080</ArticleId><ArticleId IdType="pmc">5132189</ArticleId></ArticleIdList></Reference><Reference><Citation>Chipika, R.H., et al., The presymptomatic phase of amyotrophic lateral sclerosis: are we merely scratching the surface? J Neurol, 2020.</Citation></Reference><Reference><Citation>Devos D et al (2019) A ferroptosis-based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis. Sci Rep 9(1):2918</Citation><ArticleIdList><ArticleId IdType="pubmed">30814647</ArticleId><ArticleId IdType="pmc">6393674</ArticleId></ArticleIdList></Reference><Reference><Citation>Floeter MK, Gendron TF (2018) Biomarkers for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Associated With Hexanucleotide Expansion Mutations in C9orf72. Front Neurol 9:1063</Citation><ArticleIdList><ArticleId IdType="pubmed">30568632</ArticleId><ArticleId IdType="pmc">6289985</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H et al (2018) A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression. PLoS ONE 13(6):e0198116</Citation><ArticleIdList><ArticleId IdType="pubmed">29870556</ArticleId><ArticleId IdType="pmc">5988280</ArticleId></ArticleIdList></Reference><Reference><Citation>Omer T et al (2017) Neuroimaging patterns along the ALS-FTD spectrum: a multiparametric imaging study. Amyotroph Lateral Scler Frontotemporal Degener 18(7&#x2013;8):611&#x2013;623</Citation><ArticleIdList><ArticleId IdType="pubmed">28562080</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Querin G, Pradat PF (2018) The changing landscape of motor neuron disease imaging: the transition from descriptive studies to precision clinical tools. Curr Opin Neurol 31(4):431&#x2013;438</Citation><ArticleIdList><ArticleId IdType="pubmed">29750730</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke, R.A.L., et al., The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis. NeuroImage: Clinical, 2018. 17: p. 953&#x2013;961.</Citation></Reference><Reference><Citation>Trojsi, F., et al., Neurodegeneration of brain networks in the amyotrophic lateral sclerosis-frontotemporal lobar degeneration (ALS-FTLD) continuum: evidence from MRI and MEG studies. CNS Spectr, 2017: p. 1&#x2013;10.</Citation></Reference><Reference><Citation>Trojsi, F., et al., Hippocampal connectivity in Amyotrophic Lateral Sclerosis (ALS): more than Papez circuit impairment. Brain Imaging Behav, 2020.</Citation></Reference><Reference><Citation>Bede P et al (2016) The selective anatomical vulnerability of ALS: &#x201c;disease-defining&#x201d; and &#x201c;disease-defying&#x201d; brain regions. Amyotroph Lateral Scler Frontotemporal Degener 17(7&#x2013;8):561&#x2013;570</Citation><ArticleIdList><ArticleId IdType="pubmed">27087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi F et al (2018) Clinical and Radiological Markers of Extra-Motor Deficits in Amyotrophic Lateral Sclerosis. Front Neurol 9:1005</Citation><ArticleIdList><ArticleId IdType="pubmed">30524366</ArticleId><ArticleId IdType="pmc">6262087</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F et al (2009) Longitudinal assessment of grey matter contraction in amyotrophic lateral sclerosis: A tensor based morphometry study. Amyotroph Lateral Scler 10(3):168&#x2013;174</Citation><ArticleIdList><ArticleId IdType="pubmed">19058055</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Hardiman O (2018) Longitudinal structural changes in ALS: a three time-point imaging study of white and gray matter degeneration. Amyotroph Lateral Scler Frontotemporal Degener 19(3&#x2013;4):232&#x2013;241</Citation><ArticleIdList><ArticleId IdType="pubmed">29214883</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier JM et al (2020) Connectome-Based Propagation Model in Amyotrophic Lateral Sclerosis. Ann Neurol 87(5):725&#x2013;738</Citation><ArticleIdList><ArticleId IdType="pubmed">32072667</ArticleId><ArticleId IdType="pmc">7186838</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C, Hardiman O, Bede P (2017) Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristics. BMC Neurol 17(1):73</Citation><ArticleIdList><ArticleId IdType="pubmed">28412941</ArticleId><ArticleId IdType="pmc">5393027</ArticleId></ArticleIdList></Reference><Reference><Citation>Welsh RC, Jelsone-Swain LM, Foerster BR (2013) The utility of independent component analysis and machine learning in the identification of the amyotrophic lateral sclerosis diseased brain. Front Hum Neurosci 7:251</Citation><ArticleIdList><ArticleId IdType="pubmed">23772210</ArticleId><ArticleId IdType="pmc">3677153</ArticleId></ArticleIdList></Reference><Reference><Citation>Grollemund V et al (2019) Machine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions. Front Neurosci 13:135</Citation><ArticleIdList><ArticleId IdType="pubmed">30872992</ArticleId><ArticleId IdType="pmc">6403867</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G et al (2018) Multimodal spinal cord MRI offers accurate diagnostic classification in ALS. J Neurol Neurosurg Psychiatry 89(11):1220&#x2013;1221</Citation><ArticleIdList><ArticleId IdType="pubmed">29353238</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster BR et al (2014) Multimodal MRI as a diagnostic biomarker for amyotrophic lateral sclerosis. Ann Clin Transl Neurol 1(2):107&#x2013;114</Citation><ArticleIdList><ArticleId IdType="pubmed">25356389</ArticleId><ArticleId IdType="pmc">4212480</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahedl M (2020) Towards individualized cortical thickness assessment for clinical routine. J Transl Med 18(1):151</Citation><ArticleIdList><ArticleId IdType="pubmed">32245485</ArticleId><ArticleId IdType="pmc">7118882</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuter M, Rosas HD, Fischl B (2010) Highly accurate inverse consistent registration: a robust approach. Neuroimage 53(4):1181&#x2013;1196</Citation><ArticleIdList><ArticleId IdType="pubmed">20637289</ArticleId><ArticleId IdType="pmc">2946852</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Burgh HK et al (2020) Multimodal longitudinal study of structural brain involvement in amyotrophic lateral sclerosis. Neurology 94(24):e2592&#x2013;e2604</Citation><ArticleIdList><ArticleId IdType="pubmed">32414878</ArticleId><ArticleId IdType="pmc">7455328</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR et al (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1(5):293&#x2013;299</Citation></Reference><Reference><Citation>Dale AM, Fischl B, Sereno MI (1999) Cortical surface-based analysis. I Segmentation and surface reconstruction. Neuroimage 9(2):179&#x2013;194</Citation><ArticleIdList><ArticleId IdType="pubmed">9931268</ArticleId><ArticleId IdType="pmc">9931268</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischl, B., M.I. Sereno, and A.M. Dale, Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage, 1999. 9(2): p. 195&#x2013;207.</Citation></Reference><Reference><Citation>Fischl B (2012) FreeSurfer. Neuroimage 62(2):774&#x2013;781</Citation><ArticleIdList><ArticleId IdType="pubmed">3685476</ArticleId><ArticleId IdType="pmc">3685476</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickie EW et al (2019) Ciftify: A framework for surface-based analysis of legacy MR acquisitions. Neuroimage 197:818&#x2013;826</Citation><ArticleIdList><ArticleId IdType="pubmed">31091476</ArticleId><ArticleId IdType="pmc">6675413</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer A et al (2018) Local-Global Parcellation of the Human Cerebral Cortex from Intrinsic Functional Connectivity MRI. Cereb Cortex 28(9):3095&#x2013;3114</Citation><ArticleIdList><ArticleId IdType="pubmed">28981612</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo BT et al (2011) The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J Neurophysiol 106(3):1125&#x2013;1165</Citation><ArticleIdList><ArticleId IdType="pubmed">21653723</ArticleId></ArticleIdList></Reference><Reference><Citation>McFarquhar M et al (2016) Multivariate and repeated measures (MRM): A new toolbox for dependent and multimodal group-level neuroimaging data. Neuroimage 132:373&#x2013;389</Citation><ArticleIdList><ArticleId IdType="pubmed">26921716</ArticleId><ArticleId IdType="pmc">4862963</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinheiro, J., et al., nlme: Linear and Nonlinear Mixed Effects Models. R package version 3.1, 2016. R Core Team.</Citation></Reference><Reference><Citation>Laird NM, Ware JH (1982) Random-effects models for longitudinal data. Biometrics 38(4):963&#x2013;974</Citation><ArticleIdList><ArticleId IdType="pubmed">7168798</ArticleId></ArticleIdList></Reference><Reference><Citation>Luders, E., A.W. Toga, and P.M. Thompson, Why size matters: Differences in brain volume account for apparent sex differences in callosal anatomy: The sexual dimorphism of the corpus callosum. Neuroimage, 2013. 84c: p. 820&#x2013;824.</Citation></Reference><Reference><Citation>Bede P et al (2014) Sexual dimorphism in ALS: exploring gender-specific neuroimaging signatures. Amyotroph Lateral Scler Frontotemporal Degener 15(3&#x2013;4):235&#x2013;243</Citation><ArticleIdList><ArticleId IdType="pubmed">24344910</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzler K et al (2011) Men and women are different: diffusion tensor imaging reveals sexual dimorphism in the microstructure of the thalamus, corpus callosum and cingulum. Neuroimage 54(4):2557&#x2013;2562</Citation><ArticleIdList><ArticleId IdType="pubmed">21087671</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Spinelli EG, Filippi M (2018) Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses. Expert Rev Neurother 18(5):395&#x2013;406</Citation><ArticleIdList><ArticleId IdType="pubmed">29630421</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi F et al (2018) The Clinical and Radiological Spectrum of Hippocampal Pathology in Amyotrophic Lateral Sclerosis. Front Neurol 9:523</Citation><ArticleIdList><ArticleId IdType="pubmed">30018591</ArticleId><ArticleId IdType="pmc">6037820</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P et al (2019) Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study. Neuroimage Clin 24:102054</Citation><ArticleIdList><ArticleId IdType="pubmed">31711033</ArticleId><ArticleId IdType="pmc">6849418</ArticleId></ArticleIdList></Reference><Reference><Citation>Chipika RH et al (2020) &#x201c;Switchboard&#x201d; malfunction in motor neuron diseases: Selective pathology of thalamic nuclei in amyotrophic lateral sclerosis and primary lateral sclerosis. Neuroimage Clin 27:102300</Citation><ArticleIdList><ArticleId IdType="pubmed">32554322</ArticleId><ArticleId IdType="pmc">7303672</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P et al (2020) Progressive brainstem pathology in motor neuron diseases: Imaging data from amyotrophic lateral sclerosis and primary lateral sclerosis. Data Brief 29:105229</Citation><ArticleIdList><ArticleId IdType="pubmed">32083157</ArticleId><ArticleId IdType="pmc">7016370</ArticleId></ArticleIdList></Reference><Reference><Citation>Feron M et al (2018) Extrapyramidal deficits in ALS: a combined biomechanical and neuroimaging study. J Neurol 265(9):2125&#x2013;2136</Citation><ArticleIdList><ArticleId IdType="pubmed">29995291</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E et al (2019) Primary lateral sclerosis: a distinct entity or part of the ALS spectrum? Amyotroph Lateral Scler Frontotemporal Degener 20(3&#x2013;4):133&#x2013;145</Citation><ArticleIdList><ArticleId IdType="pubmed">30654671</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebouteux MV et al (2014) Revisiting the spectrum of lower motor neuron diseases with snake eyes appearance on magnetic resonance imaging. Eur J Neurol 21(9):1233&#x2013;1241</Citation><ArticleIdList><ArticleId IdType="pubmed">24847978</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke T et al (2016) Measurement of Social Cognition in Amyotrophic Lateral Sclerosis: A Population Based Study. PLoS ONE 11(8):e0160850</Citation><ArticleIdList><ArticleId IdType="pubmed">27556398</ArticleId><ArticleId IdType="pmc">4996502</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi F et al (2020) Neuroimaging data indicate divergent mesial temporal lobe profiles in amyotrophic lateral sclerosis, Alzheimer&#x2019;s disease and healthy aging. Data Brief 28:104991</Citation><ArticleIdList><ArticleId IdType="pubmed">31921944</ArticleId></ArticleIdList></Reference><Reference><Citation>Abidi, M., et al., Adaptive functional reorganization in amyotrophic lateral sclerosis: coexisting degenerative and compensatory changes. Eur J Neurol, 2019.</Citation></Reference><Reference><Citation>Yunusova Y et al (2019) Clinical Measures of Bulbar Dysfunction in ALS. Front Neurol 10:106</Citation><ArticleIdList><ArticleId IdType="pubmed">30837936</ArticleId><ArticleId IdType="pmc">6389633</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman, O., et al., Neurodegenerative Disorders: A Clinical Guide. 2016 ed. 2016, Springer Cham Heidelberg New York Dordrecht London&#xa9; Springer International Publishing Switzerland 2016: Springer International Publishing. 1&#x2013;336.</Citation></Reference><Reference><Citation>Foerster BR et al (2013) Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis. Acad Radiol 20(9):1099&#x2013;1106</Citation><ArticleIdList><ArticleId IdType="pubmed">23931423</ArticleId><ArticleId IdType="pmc">4384461</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P et al (2018) Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study. Brain Imaging Behav 12(6):1696&#x2013;1707</Citation><ArticleIdList><ArticleId IdType="pubmed">29423814</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng HJ et al (2016) Widespread structural brain involvement in ALS is not limited to the C9orf72 repeat expansion. J Neurol Neurosurg Psychiatry 87(12):1354&#x2013;1360</Citation><ArticleIdList><ArticleId IdType="pubmed">27756805</ArticleId><ArticleId IdType="pmc">5136726</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E et al (2019) The clinical and radiological profile of primary lateral sclerosis: a population-based study. J Neurol 266(11):2718&#x2013;2733</Citation><ArticleIdList><ArticleId IdType="pubmed">31325016</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F et al (2016) Structural brain correlates of cognitive and behavioral impairment in MND. Hum Brain Mapp 37(4):1614&#x2013;1626</Citation><ArticleIdList><ArticleId IdType="pubmed">26833930</ArticleId><ArticleId IdType="pmc">6867462</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E et al (2019) Widespread subcortical grey matter degeneration in primary lateral sclerosis: a multimodal imaging study with genetic profiling. Neuroimage Clin 24:102089</Citation><ArticleIdList><ArticleId IdType="pubmed">31795059</ArticleId><ArticleId IdType="pmc">6978214</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P et al (2017) Virtual brain biopsies in amyotrophic lateral sclerosis: Diagnostic classification based on in vivo pathological patterns. Neuroimage Clin 15:653&#x2013;658</Citation><ArticleIdList><ArticleId IdType="pubmed">28664036</ArticleId><ArticleId IdType="pmc">5479963</ArticleId></ArticleIdList></Reference><Reference><Citation>Grollemund V et al (2020) Development and validation of a 1-year survival prognosis estimation model for Amyotrophic Lateral Sclerosis using manifold learning algorithm UMAP. Sci Rep 10(1):13378</Citation><ArticleIdList><ArticleId IdType="pubmed">32770027</ArticleId><ArticleId IdType="pmc">7414917</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F et al (2010) MRI predictors of long-term evolution in amyotrophic lateral sclerosis. Eur J Neurosci 32(9):1490&#x2013;1496</Citation><ArticleIdList><ArticleId IdType="pubmed">21044177</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng, H.J., et al., Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol, 2018.</Citation></Reference><Reference><Citation>Elamin M et al (2015) Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm. J Neurol 262(6):1447&#x2013;1454</Citation><ArticleIdList><ArticleId IdType="pubmed">25860344</ArticleId><ArticleId IdType="pmc">4469087</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippi M et al (1998) Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Ann Neurol 43(4):499&#x2013;506</Citation><ArticleIdList><ArticleId IdType="pubmed">9546332</ArticleId></ArticleIdList></Reference><Reference><Citation>Househam E, Swash M (2000) Diagnostic delay in amyotrophic lateral sclerosis: what scope for improvement? J Neurol Sci 180(1&#x2013;2):76&#x2013;81</Citation><ArticleIdList><ArticleId IdType="pubmed">11090869</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraemer M, Buerger M, Berlit P (2010) Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis. Clin Neurol Neurosurg 112(2):103&#x2013;105</Citation><ArticleIdList><ArticleId IdType="pubmed">19931253</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoccolella S et al (2006) Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study. J Neurol Sci 250(1&#x2013;2):45&#x2013;49</Citation><ArticleIdList><ArticleId IdType="pubmed">16920152</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M et al (2017) Identifying behavioural changes in ALS: Validation of the Beaumont Behavioural Inventory (BBI). Amyotroph Lateral Scler Frontotemporal Degener 18(1&#x2013;2):68&#x2013;73</Citation><ArticleIdList><ArticleId IdType="pubmed">27894191</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum, J.M., et al., The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci, 1999. 169(1&#x2013;2): p. 13&#x2013;21.</Citation></Reference><Reference><Citation>Burke T et al (2017) Visual encoding, consolidation, and retrieval in amyotrophic lateral sclerosis: executive function as a mediator, and predictor of performance. Amyotroph Lateral Scler Frontotemporal Degener 18(3&#x2013;4):193&#x2013;201</Citation><ArticleIdList><ArticleId IdType="pubmed">28084080</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J et al (2014) TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol 128(3):423&#x2013;437</Citation><ArticleIdList><ArticleId IdType="pubmed">24916269</ArticleId><ArticleId IdType="pmc">4384652</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J et al (2013) Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 74(1):20&#x2013;38</Citation><ArticleIdList><ArticleId IdType="pubmed">23686809</ArticleId><ArticleId IdType="pmc">3785076</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M et al (2013) Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology 80(17):1590&#x2013;1597</Citation><ArticleIdList><ArticleId IdType="pubmed">23553481</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng HJ et al (2015) Subcortical structures in amyotrophic lateral sclerosis. Neurobiol Aging 36(2):1075&#x2013;1082</Citation><ArticleIdList><ArticleId IdType="pubmed">25281019</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat PF, El Mendili MM (2014) Neuroimaging to investigate multisystem involvement and provide biomarkers in amyotrophic lateral sclerosis. Biomed Res Int 2014:467560</Citation><ArticleIdList><ArticleId IdType="pubmed">24949452</ArticleId><ArticleId IdType="pmc">4052676</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat P-F et al (2009) Extrapyramidal stiffness in patients with amyotrophic lateral sclerosis. Mov Disord 24(14):2143&#x2013;2148</Citation><ArticleIdList><ArticleId IdType="pubmed">19735090</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C et al (2016) The segmental diffusivity profile of amyotrophic lateral sclerosis associated white matter degeneration. Eur J Neurol 23(8):1361&#x2013;1371</Citation><ArticleIdList><ArticleId IdType="pubmed">27207250</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi F et al (2014) Uncinate fasciculus microstructure and verbal episodic memory in amyotrophic lateral sclerosis: a diffusion tensor imaging and neuropsychological study. Brain Imaging Behav 8(4):497&#x2013;505</Citation><ArticleIdList><ArticleId IdType="pubmed">24190400</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F et al (2014) Intrahemispheric and interhemispheric structural network abnormalities in PLS and ALS. Hum Brain Mapp 35(4):1710&#x2013;1722</Citation><ArticleIdList><ArticleId IdType="pubmed">23633431</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F et al (2014) Resting state functional connectivity alterations in primary lateral sclerosis. Neurobiol Aging 35(4):916&#x2013;925</Citation><ArticleIdList><ArticleId IdType="pubmed">24211007</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasseroleslami B et al (2019) Characteristic Increases in EEG Connectivity Correlate With Changes of Structural MRI in Amyotrophic Lateral Sclerosis. Cereb Cortex 29(1):27&#x2013;41</Citation><ArticleIdList><ArticleId IdType="pubmed">29136131</ArticleId></ArticleIdList></Reference><Reference><Citation>Lule D et al (2010) Neuroimaging of multimodal sensory stimulation in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 81(8):899&#x2013;906</Citation><ArticleIdList><ArticleId IdType="pubmed">20543183</ArticleId></ArticleIdList></Reference><Reference><Citation>Lule D et al (2007) Brain responses to emotional stimuli in patients with amyotrophic lateral sclerosis (ALS). J Neurol 254(4):519&#x2013;527</Citation><ArticleIdList><ArticleId IdType="pubmed">17401515</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>